Acura Pharmaceuticals, Inc. Secures Bridge Funding
PALATINE, Ill., Nov. 30, 2006 -- Acura Pharmaceuticals, Inc. today announced it has secured gross proceeds of $534,000 and a commitment for additional funding of up to $1.466 million under a term loan agreement with Essex Woodlands Health Ventures V, L.P., Care Capital Investments II, L.P., Care Capital Offshore Investments II, L.P., Galen Partners III, L.P., Galen Partners International III,
Ford hopes new models will drive turnaround
The main difference between Ford's woes today and General Motors' dismal finish to 2005 is that GM had a big hitter due up in the new SUVs and pickups it has introduced this year.